1. Home
  2. BMEA vs SBT Comparison

BMEA vs SBT Comparison

Compare BMEA & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • SBT
  • Stock Information
  • Founded
  • BMEA 2017
  • SBT 1984
  • Country
  • BMEA United States
  • SBT United States
  • Employees
  • BMEA N/A
  • SBT N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • SBT Savings Institutions
  • Sector
  • BMEA Health Care
  • SBT Finance
  • Exchange
  • BMEA Nasdaq
  • SBT Nasdaq
  • Market Cap
  • BMEA 275.6M
  • SBT 244.9M
  • IPO Year
  • BMEA 2021
  • SBT 2017
  • Fundamental
  • Price
  • BMEA $6.38
  • SBT $4.79
  • Analyst Decision
  • BMEA Buy
  • SBT
  • Analyst Count
  • BMEA 13
  • SBT 0
  • Target Price
  • BMEA $37.25
  • SBT N/A
  • AVG Volume (30 Days)
  • BMEA 814.9K
  • SBT 29.1K
  • Earning Date
  • BMEA 10-29-2024
  • SBT 10-30-2024
  • Dividend Yield
  • BMEA N/A
  • SBT N/A
  • EPS Growth
  • BMEA N/A
  • SBT N/A
  • EPS
  • BMEA N/A
  • SBT 0.12
  • Revenue
  • BMEA N/A
  • SBT $67,988,000.00
  • Revenue This Year
  • BMEA N/A
  • SBT N/A
  • Revenue Next Year
  • BMEA N/A
  • SBT $6.68
  • P/E Ratio
  • BMEA N/A
  • SBT $40.70
  • Revenue Growth
  • BMEA N/A
  • SBT N/A
  • 52 Week Low
  • BMEA $3.61
  • SBT $4.40
  • 52 Week High
  • BMEA $22.74
  • SBT $6.01
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 24.23
  • SBT 51.71
  • Support Level
  • BMEA $6.04
  • SBT $4.81
  • Resistance Level
  • BMEA $9.34
  • SBT $4.83
  • Average True Range (ATR)
  • BMEA 0.54
  • SBT 0.07
  • MACD
  • BMEA -0.26
  • SBT 0.01
  • Stochastic Oscillator
  • BMEA 10.30
  • SBT 44.83

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About SBT Sterling Bancorp Inc.

Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.

Share on Social Networks: